Sanctuary Advisors’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
39,096
+319
+0.8% +$10.1K 0.01% 1367
2026
Q1
$1.22M Buy
38,777
+18,492
+91% +$583K 0.01% 1221
2025
Q4
$598K Buy
20,285
+6,384
+46% +$177K ﹤0.01% 1624
2025
Q3
$351K Buy
+13,901
New +$339K ﹤0.01% 1908
2025
Q1
Sell
-8,995
Closed -$226K 2411
2024
Q4
$226K Sell
8,995
-128
-1% -$3.24K ﹤0.01% 2178
2024
Q3
$237K Sell
9,123
-20,211
-69% -$599K ﹤0.01% 2148
2024
Q2
$769K Buy
+29,334
New +$814K 0.01% 1349

Other funds holding RTO

Sanctuary Advisors's RTO Position: Q2 2026 in Review

Sanctuary Advisors increased its Rentokil (RTO) stake by 0.82% in Q2 2026, buying an estimated $10.1K and bringing the position to 39,096 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #1367.

Sanctuary Advisors first reported a position in RTO in Q2 2024 and has held it in 7 quarters since. The position peaked at $1.22M in Q1 2026. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Sanctuary Advisors held 39,096 shares of Rentokil worth $1.12M as of Q2 2026.
  • Sanctuary Advisors bought 319 Rentokil shares in Q2 2026, an estimated $10.1K.
  • Rentokil made up 0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1367 holding.
  • Sanctuary Advisors first reported a position in Rentokil in Q2 2024 and has held it in 7 quarters since.
  • Sanctuary Advisors's Rentokil position peaked at $1.22M in Q1 2026.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.